These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 861959)
1. The carcinoid syndrome--a role for hemodialysis. Creagan ET; Tyce GM; Moertel CG Cancer Treat Rep; 1977; 61(1):107-8. PubMed ID: 861959 [No Abstract] [Full Text] [Related]
2. [Current views on carcinoid and the carcinoid syndrome]. Ryss ES Klin Med (Mosk); 1971 Jan; 49(1):13-9. PubMed ID: 4396993 [No Abstract] [Full Text] [Related]
3. Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome. Engelman K; Lovenberg W; Sjoerdsma A N Engl J Med; 1967 Nov; 277(21):1103-8. PubMed ID: 6054996 [No Abstract] [Full Text] [Related]
4. Carcinoid syndrome. Rose D Am J Nurs; 1980 Jan; 80(1):110-12. PubMed ID: 6153138 [No Abstract] [Full Text] [Related]
5. Study of a possible physiologic interaction between ceruloplasmin and serotonin. Warner RR; Sternlieb I J Lab Clin Med; 1966 Jun; 67(6):934-6. PubMed ID: 5916141 [No Abstract] [Full Text] [Related]
6. The malignant carcinoid syndrome. Davis Z; Moertel CG; McIlrath DC Surg Gynecol Obstet; 1973 Oct; 137(4):637-44. PubMed ID: 4730072 [No Abstract] [Full Text] [Related]
7. Some newer aspects of the carcinoid syndrome. Eiband JM; Brown H; Gregory CH; Kahil ME Tex Med; 1966 Dec; 62(12):62-5. PubMed ID: 5980426 [No Abstract] [Full Text] [Related]
8. Effects of somatostatin infusion in four patients with malignant carcinoid syndrome. Quatrini M; Basilisco G; Conte D; Bozzani A; Bardella MT; Bianchi PA Am J Gastroenterol; 1983 Mar; 78(3):149-51. PubMed ID: 6187212 [TBL] [Abstract][Full Text] [Related]
9. The carcinoid syndrome: neuroendocrine and chemical considerations. Aleshire SL; Bradley CA; Parl FF Clin Lab Med; 1984 Dec; 4(4):803-15. PubMed ID: 6210171 [TBL] [Abstract][Full Text] [Related]
11. Hepatic dearterialization in the treatment of carcinoid syndrome. Sjöblom SM; Höckerstedt K; Järvinen H Acta Chir Scand; 1987 Sep; 153(9):523-9. PubMed ID: 2447716 [TBL] [Abstract][Full Text] [Related]
12. The carcinoid syndrome: methods of treatment and recent experience with hepatic artery ligation and infusion. Farndon JR Clin Oncol; 1977 Dec; 3(4):365-75. PubMed ID: 598064 [No Abstract] [Full Text] [Related]
13. Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome. Moertel CG; O'Connell MJ; Reitemeier RJ; Rubin J Cancer Treat Rep; 1984 Apr; 68(4):665-7. PubMed ID: 6201271 [TBL] [Abstract][Full Text] [Related]
14. [Ileal carcinoid tumors. Predominant lesions of the left endocardium]. Warter J; Batzenschlager A; Schirardin H; Grappe JM; Berthier G; Monath C Ann Med Interne (Paris); 1971 Oct; 122(10):967-74. PubMed ID: 5150731 [No Abstract] [Full Text] [Related]
15. [The syndrome of metastazing carcinoid. 3. Long-term follow up of 5-hydroxyindoleacetic acid excretion in the urine]. Simon J; Láhn V; Opatrný K; Sova J; Sídlová A; Cerhová M; Hůla J; Virt S Cas Lek Cesk; 1968 Mar; 107(13):394-8. PubMed ID: 5664817 [No Abstract] [Full Text] [Related]
16. Discussion of the role of 5-hydroxyindoles in the carcinoid syndrome. Davis VE Adv Pharmacol (1962); 1968; 6(Pt B):143-5. PubMed ID: 5658312 [No Abstract] [Full Text] [Related]
17. Distinguishing features of idiopathic flushing and carcinoid syndrome. Aldrich LB; Moattari AR; Vinik AI Arch Intern Med; 1988 Dec; 148(12):2614-8. PubMed ID: 2461688 [TBL] [Abstract][Full Text] [Related]